Does a human rights-based approach to harm reduction support commercialized harm reduction? Brief research

被引:0
作者
Sircar, Neil [1 ]
Fleming, Mary E. [2 ]
Bialous, Stella A. [3 ]
机构
[1] Mitchell Hamline Sch Law, Publ Hlth Law Ctr, St Paul, MN 55105 USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] UC San Francisco, Dept Social & Behav Sci, San Francisco, CA USA
关键词
tobacco and tobacco product; human rights; harm reduction; public health; human rights-based approach (HRBA);
D O I
10.3389/fpubh.2022.1001036
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In recent years, the tobacco industry has been pushing a narrative that their newer lines of products-including electronic nicotine delivery devices-are offered in part to meet a social responsibility of providing potentially reduced-harm choices to their consumers. While some of the newer tobacco products might potentially be less harmful than combustible tobacco products, there is also significant deviation from the very concept of harm reduction when it is used for such a conspicuously commercialized purpose. The framing of commercialized tobacco harm reduction as a mere consumer preference by the industry is not clearly consistent with the core principles of harm reduction, let alone the human right to health and the highest attainable level of health. A human rights-based approach (HRBA) to harm reduction is a set of principles that frame an effort to respect and promote human rights, including the right to health. Whether the HRBA supports commercialized harm reduction requires study. We review industry materials from 2017 to 2022 to identify themes in the harm reduction narrative of the tobacco industry and analyse those themes using an HRBA to the tobacco harm reduction framework. Using this analysis, the industry's continued marketing of combustible products alongside their "potentially less harmful" products, and preference that their non-combustible products be regulated less strictly than cigarettes and cigars, adulterates the public health principles of harm reduction and undermines the right to health. We conclude that the tobacco industry's commercialized tobacco harm reduction is incompatible with a human rights-based approach to tobacco harm reduction.
引用
收藏
页数:9
相关论文
共 71 条
[1]  
Altria, 2021, RED HARM TOB PROD 20
[2]  
Altria, 2022, RED HARM TOB PROD
[3]  
Altria, 2018, ALTR MAK 12 8 BILL M
[4]  
Altria, 2021, 2021 CORP RESP PROGR
[5]  
Altria, 2022, ESG REP DAT
[6]  
Altria, 2022, AD SMOK 21 SHOULD HA
[7]  
Altria, REG FLAV TOB PROD
[8]  
Altria, 2022, COMM TOB HLTH EFF
[9]  
Altria, 2017, RE DOCK NO FDA 2016
[10]  
Altria, MOV SMOK